Eyebrow Regrowth in Patients with Frontal Fibrosing Alopecia Treated with Intralesional Triamcinolone Acetonide

    Jeff Donovan, Aman Samrao, Beth S. Ruben, Vera H. Price
    Studysummary In this study, intralesional triamcinolone acetonide was associated with eyebrow regrowth in some patients with frontal fibrosing alopecia. Our plain-language summary of this paper — not a Tressless recommendation.
    The study investigated the effectiveness of intralesional triamcinolone acetonide in promoting eyebrow regrowth in patients with frontal fibrosing alopecia (FFA). The treatment showed promising results, with a significant number of patients experiencing noticeable regrowth of their eyebrows. This finding suggested that intralesional triamcinolone acetonide could be a viable therapeutic option for managing eyebrow loss in FFA patients. The study provided a potential new avenue for treatment, contributing valuable insights into the management of this challenging condition.
    Discuss this study in the Community →

    Research cited in this study

    9 / 9 results